Jim Simons acquired 736k Annovis Bio shares worth $626k. That's 0.00% of their equity portfolio (2374th largest holding). The investor owns 1.73% of the outstanding Annovis Bio stock. The first Annovis Bio trade was made in Q3 2020. Since then Jim Simons bought shares six more times and sold shares on six occasions. The investor's estimated purchase price is $1.64M, resulting in a loss of 62%.